Delivery Order SPE2DR25D7905-SPE2DR26F8LHT
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Haloperidol 1 mg tablets in quantities of 1,000 units. This competitively awarded, firm fixed-price contract carries a ceiling value of $3,165.06 and is scheduled for completion by August 18, 2025. The delivery order was issued under a non-set-aside procurement process, reflecting open competition among qualified pharmaceutical distributors....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,923.29 on August 14, 2025, for the supply of Haloperidol 1 mg tablets in quantities of 1,000 units. This firm fixed-price, non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 15, 2025. The award represents a child delivery order under AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Haloperidol 1 mg tablets. The contract has a firm fixed price of $1,526.97 and a completion date of September 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the supply of a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Haloperidol Lactate 5 mg/mL vials. The firm fixed-price contract, valued at $1,150.96, has a completion date of September 3, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical...
- The Defense Logistics Agency awarded a $61,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 2 mg tablets of haloperidol each. The delivery order was issued against an existing Prime Vendor contract vehicle and calls for shipment of the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 7, 2023 to support the Agency's medical supply needs. Amerisourcebergen will perform as the prime contractor without the...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $127.71 to Amerisourcebergen Drug Corp Corporate Office Division for 4561920611 HALOPERIDOL LAC 5 MG/ML VIALML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the place of performance in Conshohocken, Pennsylvania by August 25, 2023 to support DLA Troop Support Medical programs. Amerisourcebergen Corporation is the parent company of...
- The Defense Logistics Agency Troop Support Medical awarded a $60,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562013527 HALOPERIDOL LAC 5 MG/ML VIALML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 31, 2023 through September 1, 2023. No subcontractors or set aside designations were identified. This delivery order is likely associated with DLA Troop Support Medical's...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $46,870 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply haloperidol lactate 5 mg/ml vials. Performance will take place in Conshohocken, Pennsylvania over one day in July 2023. The funding agency, DLA Troop Support Medical, supports the medical readiness of the Department of Defense through procurement and distribution activities. No subcontractors or...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Hysingla ER 40 mg tablets (60-count units) with a contract value of $1,306.23. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery is scheduled for completion by October 21, 2025,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,082.52 to AmerisourceBergen Drug Corp on January 8, 2026, for pharmaceutical products specified as "4570439817 ! DT 1C 2.25X4 700/RL 6RL/BX DHAPCL" with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order was awarded without set-aside designation under competitive procedures and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- SPE2DR25D7905Indefinite Delivery Contract
- SPE2DR25D7905-SPE2DR26F8LHTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Haloperidol 1 mg tablets in quantities of 1,000 units, with a ceiling value of $1,197.26. This is a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and represents performance at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements in open competition. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, generic and brand-name drugs, and related medical commodities. The pharmaceutical supply chain support provided under this contract is critical to sustaining Defense Health Agency operations and other federal medical institutions requiring consistent access to essential medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/12/26 |